Literature DB >> 33382912

Thrombotic thrombocytopenic purpura as the initial presentation of COVID-19.

Marie-Claude Beaulieu1, Danny Sebastien Mettelus1, Benjamin Rioux-Massé2, Michèle Mahone1,3.   

Abstract

Entities:  

Keywords:  SARS-COV-2; inflammation; microangiopathy; thrombopenia; thrombotic thrombocytopenic purpura

Mesh：

Substances：

Year:  2021        PMID： 33382912     DOI： 10.1111/jth.15231

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  5 in total

Review 1.  Flavorubredoxin, a Candidate Trigger Related to Thrombotic Thrombocytopenic Purpura: Screening of the Complete Genome of a Salmonella enterica Serovar Typhimurium Isolate From an AIDS Case.

Authors:  Zhouhan Wang; Hao Xu; Beiqing Gu; Yanqi Jin; Tianyuan Wang; Jindi Ma; Yingfeng Lu; Xiaopeng Yu; Beiwen Zheng; Yimin Zhang
Journal:  Front Cell Infect Microbiol       Date:  2022-06-10       Impact factor: 6.073

Review 2.  Prognostic value of von Willebrand factor and ADAMTS13 in patients with COVID-19: A systematic review and meta-analysis.

Authors:  Xin Xu; Yao Feng; Yitong Jia; Xiao Zhang; Long Li; Xuesong Bai; Liqun Jiao
Journal:  Thromb Res       Date:  2022-08-18       Impact factor: 10.407

Review 3.  COVID-19-Associated Thrombotic Thrombocytopenic Purpura: A Case Report and Systematic Review.

Authors:  Haseeb Chaudhary; Usama Nasir; Khezar Syed; Maria Labra; Christopher Reggio; Ansar Aziz; Parin Shah; Roopika Reddy; Navdeep Sangha
Journal:  Hematol Rep       Date:  2022-08-02

4.  Relapse of immune thrombotic thrombocytopenic purpura (iTTP) possibly triggered by COVID-19 vaccination and/or concurrent COVID-19 infection.

Authors:  Fei Fang; Brandon Tse; Katerina Pavenski
Journal:  BMJ Case Rep       Date:  2022-07-28

Review 5.  Coronavirus Disease 2019-Associated Thrombotic Microangiopathy: Literature Review.

Authors:  Marija Malgaj Vrečko; Andreja Aleš Rigler; Željka Večerić-Haler
Journal:  Int J Mol Sci       Date:  2022-09-25       Impact factor: 6.208
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.